Femtosecond lasers for laser in situ keratomileusis: a systematic review and meta-analysis
Received 28 October 2015
Accepted for publication 26 January 2016
Published 7 March 2016 Volume 2016:10 Pages 393—404
Checked for plagiarism Yes
Review by Single-blind
Peer reviewers approved by Dr Aphrodite Stavropoulos
Peer reviewer comments 2
Editor who approved publication: Dr Scott Fraser
Anne Huhtala,1 Juhani Pietilä,1,2 Petri Mäkinen,1,2 Hannu Uusitalo1–3
1Silmäasema Eye Hospital, 2SILK, Department of Ophthalmology, School of Medicine, University of Tampere, 3TAUH Eye Center, Tampere University Hospital, Tampere, Finland
Purpose: The aim of this study was to review and meta-analyze whether there are differences between reported femtosecond (FS) lasers for laser-assisted in situ keratomileusis (LASIK) in terms of efficacy, predictability, and safety as primary outcomes and corneal flap thickness measurements and pre- and postoperative complications as secondary outcomes.
Methods: A comprehensive literature search of PubMed, Science Direct, Scopus, and Cochrane CENTRAL Trials Library databases was conducted to identify the relevant prospective randomized controlled trials of FS lasers for LASIK. Thirty-one articles describing a total of 5,404 eyes were included.
Results: Based on efficacy, IntraLase FS 10 and 30 kHz gave the best results. Based on predictability and safety, there were no differences between various FS lasers. FEMTO LDV and IntraLase FS 60 kHz produced the most accurate flap thicknesses. IntraLase and Wavelight SF200 had the fewest intraoperative complications. IntraLase, Visumax, and Wavelight FS200 had the most seldom postoperative complications.
Conclusion: There were dissimilarities between different FS lasers based on efficacy and intraoperative and postoperative complications. All FS lasers were predictable and safe for making corneal flaps in LASIK.
Keywords: femtosecond laser, laser in situ keratomileusis, LASIK, meta-analysis
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]